1Stetler-Stevenson M, Arthur D C, Jabbour N, et al. Diagnostic u-tility of flow cytometric immunophenotyping in myelodysplasticsyndrome[J]. Blood,2001,98(4):979-987. 被引量：1
2Valent P, Homy H P, Bennett J M, et al. Definitions and standardsin the diagnosis and treatment of the myelodysplastic syndromes:Consensus statements and report from a working conference [J],Leukemia Res, 2007,31(6):727-736. 被引量：1
3Ogata K, Della Porta M G, Malcovati L, et al. Diagnostic utility offlow cytometry in low-grade myelodysplastic syndromes: aprospective validation study[J]. Haematologica,2009,94(8): 1066-1074. 被引量：1
4Westers T M,Ireland R, Kern W, et al. Standardization of flow cy-tometry in myelodysplastic syndromes: a report from an interna-tional consortium and the European LeukemiaNet Working Group[J], Leukemia, 2012,26(7):1730-1741. 被引量：1
5Malcovati L, Hellstrom-Lindberg E, Bowen D, et al. Diagnosisand treatment of primary myelodysplastic syndromes in adults:recommendations from the European LeukemiaNet [J]. Blood,2013,122(17):2943-2964. 被引量：1
6Garcia-Manero G. Myelodysplastic syndromes: 2014 update ondiagnosis, risk-stratification, and management[J]. Am J Hematol,2014,89(1):97-108. 被引量：1
7Porwit A, van de Loosdrecht A A, Bettelheim P, et al. Revisitingguidelines for integration of flow cytometry results in the WHOclassification of myelodysplastic syndromes-proposal from theInternational/European LeukemiaNet Working Group for Flow Cy-tometry in MDS[J], Leukemia,2014,28(9): 1793-1798. 被引量：1
8Chopra A, Pati H, Mahapatra M, et al. Flow cytometry in myelodys-plastic syndrome: analysis of diagnostic utility using maturationpattern-based and quantitative approaches [J]. Ann Hematol,2012,91(9):1351-1362. 被引量：1
9Kern W, Haferlach C, Schnittger S, et al. Clinical utility of multipa-rameter flow cytometry in the diagnosis of 1 013 patients withsuspected myelodysplastic syndrome: correlation to cytomor-phology, cytogenetics, and clinical data[J]. Cancer,2010,116(19):4549-4563. 被引量：1
